The Nick Gilbert Neurofibromatosis Research Institute (NGNRI) is the world’s first brick-and-mortar research facility solely focused on finding a cure for neurofibromatosis or NF.
Named in memory of Nick Gilbert, who passed away from complications related to NF in 2023, NGNRI seeks to discover and develop improved treatments and cures for neurofibromatosis type 1 and other debilitating neuronal diseases and related conditions. NGNRI paves the way for more personalized health care by leveraging next generation technologies, including ‘organoids’ or organ-like assemblies grown in a lab environment, and advancing leading research. NGNRI will be housed within the Henry Ford Health + Michigan State University Health Sciences research campus.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://NGNRI.org
Ngnri Questions
Ngnri's website is http://NGNRI.org
Ngnri's LinkedIn profile is https://www.linkedin.com/company/ngnri
Ngnri's industry is
Biotechnology Research
Ngnri's top competitors are
Gilbert Family Foundation,
Chandler Symphony Orchestra,
1,000 Dreams Fund,
Icon Plc,
Aquestive Therapeutics.
Ngnri's categories are Biotechnology Research
